Treatment of hepatitis B and C following liver transplantation

被引：0
作者：
Craig A. Sponseller
Sanjay Ramrakhiani
机构：
[1] G.I.,
[2] Inc.,undefined
来源：
Current Hepatitis Reports | 2003年 / 2卷 / 2期
关键词：
Lamivudine; Sustained Virologic Response; Orthotopic Liver Transplantation; Adefovir Dipivoxil;
D O I：
10.1007/s11901-003-0023-0
中图分类号：
学科分类号：
摘要：
Advanced liver disease related to hepatitis B virus (HBV) and hepatitis C virus (HCV) is the leading indication for orthotopic liver transplantation worldwide. This article discusses the strategies for the management of liver disease related to recurrent HBV and HCV.
引用
收藏
页码：71 / 78
页数：7
相关论文
共 149 条
  • [1] Samuel D(1993)Liver transplantation in European patients with the hepatitis B surface antigen N Engl J Med 329 1842-1847
  • [2] Muller R(1997)Hepatitis B virus infection and liver transplantation Gut 40 568-571
  • [3] Alexander G(1978)Familial HBsAg-positive hepatoma: treatment with orthotopic liver transplantation and specific immunoglobulin BMJ 1 216-216
  • [4] Terrault NA(1987)Immunoprophylaxis of hepatitis B virus reinfection in recipients of human liver allografts Transplant Proc 19 2387-2389
  • [5] Wright TL(1991)Liver transplantation in HBs antigen (HBsAg) carriers. Prevention of hepatitis B virus (HBV) recurrence by passive immunization J Hepatol 13 90-96
  • [6] Johnson PJ(1991)Passive immunoprophylaxis after liver transplantation in HBsAg-positive patients Lancet 337 813-815
  • [7] Wansbrough-Jones MH(1993)Recurrent HBV/HDV infections under different immunoprophylaxis protocols Transplant Proc 25 2675-2676
  • [8] Portmann B(1997)Absence of initial viral replication and long-term high dose immunoglobulin administration improve results of hepatitis B virus recurrence prophylaxis after liver transplantation Transplant Proc 29 517-518
  • [9] Lauchart W(1996)Prevention of hepatitis B recurrence with indefinite hepatitis B immune globulin (HBIG) prophylaxis after liver transplantation Transplant Proc 10 663-667
  • [10] Muller R(1996)Prophylaxis in liver transplant recipients using a fixed dosing schedule of hepatitis B immunoglobulin Hepatology 24 1327-1333
12345678910